Share your input on improving interoperability and developing industry-wide data standards that enhance biomanufacturing productivity.
Deadline: January 30, 2026
Help first- and second-year college students explore careers in biopharma manufacturing.
Deadline: February 5, 2026
Collaborate on innovative manufacturing platforms and technologies that accelerate the development and manufacture of life-saving medicines and medical countermeasures, enhance national economic security, and support response to biothreats
Help companies de-risk the adoption and implementation of new technologies and approaches for development and manufacturing
Strengthen the U.S. economy by cultivating a world-leading biopharmaceutical workforce that meets the industry’s needs through novel training and education programs
Udit Batra, President & CEO, Waters
We achieve our mission through an RFx process that aims to advance technical and workforce development projects:
RFA: Viral Vector Capsid Titer Interlab Study (RFA2025.03)
This opportunity is now closed.
NIIMBL is pleased to announce this Request for Application (RFA) to participate in the Viral Vector Program interlab study to evaluate whether utilizing the new United States Pharmacopeia (USP) AAV9 Reference material as a calibrant can improve the accuracy and precision of AAV9 capsid titer measurements from commercial Enzyme-Linked Immunosorbent Assay (ELISA) kits.
Study Goals
NIIMBL is pleased to announce the pilot of a faculty sabbatical in industry program. The NIIMBL Faculty Fellows program provides financial support for faculty or instructional staff at universities and community colleges to pursue a sabbatical either at an industry member (Tier 1 or Tier 2) or at NIIMBL’s Headquarters (NIIMBL HQ) in Delaware to support NIIMBL-led projects.
The NIIMBL Faculty Fellows program closes December 31, 2024.
Concept submissions for Project Call 9.1 are now closed.
NIIMBL is pleased to announce Project Call 9.1, with member- driven and industry-led priority topic areas for technical development proposals.
Technology Topics:
Workforce Development Topics
We achieve our mission through an RFx process that aims to advance technical and workforce development projects:
RFA: Viral Vectors Capsid Titer
RFA: Viral Vector Capsid Titer Interlab Study (RFA2025.03)
This opportunity is now closed.
NIIMBL is pleased to announce this Request for Application (RFA) to participate in the Viral Vector Program interlab study to evaluate whether utilizing the new United States Pharmacopeia (USP) AAV9 Reference material as a calibrant can improve the accuracy and precision of AAV9 capsid titer measurements from commercial Enzyme-Linked Immunosorbent Assay (ELISA) kits.
Study Goals
RFA: Faculty Fellows
NIIMBL is pleased to announce the pilot of a faculty sabbatical in industry program. The NIIMBL Faculty Fellows program provides financial support for faculty or instructional staff at universities and community colleges to pursue a sabbatical either at an industry member (Tier 1 or Tier 2) or at NIIMBL’s Headquarters (NIIMBL HQ) in Delaware to support NIIMBL-led projects.
The NIIMBL Faculty Fellows program closes December 31, 2024.
RFP: Project Call 9.1
Concept submissions for Project Call 9.1 are now closed.
NIIMBL is pleased to announce Project Call 9.1, with member- driven and industry-led priority topic areas for technical development proposals.
Technology Topics:
Workforce Development Topics
Our members are stakeholders from across the biopharmaceutical manufacturing ecosystem, including large and small companies, academic institutions, and nonprofits.
Members have the opportunity to collectively revolutionize current biomanufacturing platforms, processes, and educational programs and share in the benefits of these transformative solutions.
The NIIMBL ecosystem’s collaborative efforts to accelerate innovative manufacturing technologies help to:
Biopharmaceuticals are medicines and medical countermeasures that save, sustain, and improve lives. They:
Mike Kress, Sr. Vice President Development Sciences and Clinical Supply,
Merck & Co., Inc.
We offer a variety of membership options that give you the flexibility to choose your organization’s level of engagement based on technology interests and priorities.
